Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 112

1.

Ex Vivo Gene Therapy: Graft-versus-host Disease (GVHD) in NSG™ (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) Mice Transplanted with CD34+ Human Hematopoietic Stem Cells.

Chandra S, Cristofori P, Fonck C, O'Neill CA.

Toxicol Pathol. 2019 May 7:192623319844484. doi: 10.1177/0192623319844484. [Epub ahead of print]

PMID:
31064282
2.

Retooling Nephrology with Ultrasound.

O'Neill WC, Ross DW.

Clin J Am Soc Nephrol. 2019 May 7;14(5):771-773. doi: 10.2215/CJN.10430818. Epub 2019 Mar 27. No abstract available.

PMID:
30917993
3.

Renal Hypertrophy in Liver Failure.

Saad M, Ellis CL, O'Neill WC.

Kidney Int Rep. 2018 Jul 6;3(6):1464-1467. doi: 10.1016/j.ekir.2018.07.004. eCollection 2018 Nov. No abstract available.

4.

Progression of Medial Arterial Calcification in CKD.

Manzoor S, Ahmed S, Ali A, Han KH, Sechopoulos I, O'Neill A, Fei B, O'Neill WC.

Kidney Int Rep. 2018 Jul 21;3(6):1328-1335. doi: 10.1016/j.ekir.2018.07.011. eCollection 2018 Nov.

5.

Investigating the Effect of Chain Connectivity on the Folding of a Beta-Sheet Protein On and Off the Ribosome.

Marsden AP, Hollins JJ, O'Neill C, Ryzhov P, Higson S, Mendonça CATF, Kwan TO, Kwa LG, Steward A, Clarke J.

J Mol Biol. 2018 Dec 7;430(24):5207-5216. doi: 10.1016/j.jmb.2018.10.011. Epub 2018 Oct 23.

6.

Immunogenicity to cerliponase alfa intracerebroventricular enzyme replacement therapy for CLN2 disease: Results from a Phase 1/2 study.

Cherukuri A, Cahan H, de Hart G, Van Tuyl A, Slasor P, Bray L, Henshaw J, Ajayi T, Jacoby D, O'Neill CA, Schweighardt B.

Clin Immunol. 2018 Dec;197:68-76. doi: 10.1016/j.clim.2018.09.003. Epub 2018 Sep 8.

PMID:
30205177
7.

Questionable specificity of histologic findings in calcific uremic arteriolopathy.

Ellis CL, O'Neill WC.

Kidney Int. 2018 Aug;94(2):390-395. doi: 10.1016/j.kint.2018.03.016. Epub 2018 Jun 7.

PMID:
29885932
8.

Pyrophosphate deficiency in vascular calcification.

Villa-Bellosta R, O'Neill WC.

Kidney Int. 2018 Jun;93(6):1293-1297. doi: 10.1016/j.kint.2017.11.035. Epub 2018 Mar 24. Review.

PMID:
29580636
9.

Point-of-care ultrasound in the practice of nephrology.

Niyyar VD, O'Neill WC.

Kidney Int. 2018 May;93(5):1052-1059. doi: 10.1016/j.kint.2017.11.032. Epub 2018 Feb 22. Review.

PMID:
29477241
10.

Gene Therapy with BMN 270 Results in Therapeutic Levels of FVIII in Mice and Primates and Normalization of Bleeding in Hemophilic Mice.

Bunting S, Zhang L, Xie L, Bullens S, Mahimkar R, Fong S, Sandza K, Harmon D, Yates B, Handyside B, Sihn CR, Galicia N, Tsuruda L, O'Neill CA, Bagri A, Colosi P, Long S, Vehar G, Carter B.

Mol Ther. 2018 Feb 7;26(2):496-509. doi: 10.1016/j.ymthe.2017.12.009. Epub 2017 Dec 14.

11.

Maternal phenylketonuria syndrome: studies in mice suggest a potential approach to a continuing problem.

Zeile WL, McCune HC, Musson DG, O'Donnell B, O'Neill CA, Tsuruda LS, Zori RT, Laipis PJ.

Pediatr Res. 2018 Apr;83(4):889-896. doi: 10.1038/pr.2017.323. Epub 2018 Jan 31.

12.

Understanding the pathogenesis of vascular calcification: timing is everything.

O'Neill WC.

Kidney Int. 2017 Dec;92(6):1316-1318. doi: 10.1016/j.kint.2017.07.020.

PMID:
29153135
13.

Introduction to Imaging in Dialysis Patients.

O'Neill WC.

Semin Dial. 2017 Jul;30(4):289. doi: 10.1111/sdi.12606. Epub 2017 May 25. No abstract available.

PMID:
28547810
14.

Partial rescue of neuropathology in the murine model of PKU following administration of recombinant phenylalanine ammonia lyase (pegvaliase).

Goldfinger M, Zeile WL, Corado CR, O'Neill CA, Tsuruda LS, Laipis PJ, Cooper JD.

Mol Genet Metab. 2017 Sep;122(1-2):33-35. doi: 10.1016/j.ymgme.2017.04.013. Epub 2017 Apr 29.

15.

Imaging for Vascular Calcification.

Raggi P, O'Neill WC.

Semin Dial. 2017 Jul;30(4):347-352. doi: 10.1111/sdi.12596. Epub 2017 Mar 22. Review.

PMID:
28332217
16.

Long-term Immunogenicity of Elosulfase Alfa in the Treatment of Morquio A Syndrome: Results From MOR-005, a Phase III Extension Study.

Long B, Tompkins T, Decker C, Jesaitis L, Khan S, Slasor P, Harmatz P, O'Neill CA, Schweighardt B.

Clin Ther. 2017 Jan;39(1):118-129.e3. doi: 10.1016/j.clinthera.2016.11.017. Epub 2016 Dec 10.

17.

Persistence of Vascular Calcification after Reversal of Uremia.

Lomashvili KA, Manning KE, Weitzmann MN, Nelea V, McKee MD, O'Neill WC.

Am J Pathol. 2017 Feb;187(2):332-338. doi: 10.1016/j.ajpath.2016.10.006. Epub 2016 Dec 8.

18.

Reveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe Disease.

Peng J, Dalton J, Butt M, Tracy K, Kennedy D, Haroldsen P, Cahayag R, Zoog S, O'Neill CA, Tsuruda LS.

J Pharmacol Exp Ther. 2017 Feb;360(2):313-323. doi: 10.1124/jpet.116.235952. Epub 2016 Nov 16.

PMID:
27856936
19.

Antibodies that neutralize cellular uptake of elosulfase alfa are not associated with reduced efficacy or pharmacodynamic effect in individuals with Morquio A syndrome.

Melton AC, Soon RK Jr, Tompkins T, Long B, Schweighardt B, Qi Y, Vitelli C, Bagri A, Decker C, O'Neill CA, Zoog SJ, Jesaitis L.

J Immunol Methods. 2017 Jan;440:41-51. doi: 10.1016/j.jim.2016.10.006. Epub 2016 Oct 24.

20.

Workshop Proceedings: Streamlined Development of Safety Assessment Programs Supporting Orphan/Rare Diseases-Are We There Yet?

Allamneni KP, Parker S, O'Neill CA, Wright TL, King S, Andrews L.

Int J Toxicol. 2016 Jul;35(4):393-409. doi: 10.1177/1091581816644709. Epub 2016 Jun 6.

PMID:
27272885

Supplemental Content

Loading ...
Support Center